
    
      Doxorubicin-Transdrugâ„¢ (DT) is a nanoparticle formulation of doxorubicin.In in vitro and in
      vivo models, DT was shown to overcome the multidrug resistance (MDR) and to be more effective
      than doxorubicin on both sensitive and resistant tumour models and in particular in the X/myc
      bi-transgenic MDR murine model of HCC.
    
  